Please assess the completion status of the following clinical trial:

Trial Title: Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age\> 18 years~* histologically confirmed breast cancer or colorectal cancer~* Patient starting oral treatment : capecitabine alone or in combination with lapatinib (can be included before the first cycle or during the first 2 cycles).~* Volunteer to participate in the study.~* ambulatory treated patient~* Able to read, write and understand French.~* Subject who accept to use MEMS monitors to automatically compile their drug dosing histories~* Written informed consent~Exclusion Criteria:~* more than 3 metastatic chemotherapies~* any severe concomitant condition which makes it undesirable for the patient to participate in the study or which would jeopardize adherence with trial protocol

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- capecitabine (Type: OTHER): patients treated by capecitabine alone (n=100)
- capecitabine + lapatinib (Type: OTHER): patients treated by capecitabine and lapatinib (n=100)

Based on this trial design, predict the completion outcome and termination type (if applicable).